During the past decade, Corporacion de Beneficencia Osorno conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Corporacion de Beneficencia Osorno" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Cogentus Pharmaceuticals" with 1 trials sponsored, "EMD Serono" with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Corporacion de Beneficencia Osorno" #1 collaborator was "BeiGene, Ltd." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Corporacion de Beneficencia Osorno" are "Arthritis, Rheumatoid" (2 trials), "Cardiovascular Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Coronary Artery Disease" (1 trials) and "Esophageal Adenocarcinoma" (1 trials). Many other conditions were trialed in "Corporacion de Beneficencia Osorno" in a lesser frequency.

Most popular intervention types in "Corporacion de Beneficencia Osorno" are "Drug" (8 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BI 695501" (2 trials), "bococizumab (PF-04950615)" (2 trials), "5-Fluorouracil" (1 trials) and "Atacicept 150 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Corporacion de Beneficencia Osorno" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Corporacion de Beneficencia Osorno". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Corporacion de Beneficencia Osorno, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Corporacion de Beneficencia Osorno, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".